Preventing, delaying, or masking type 2 diabetes with metformin in the diabetes prevention program?

Diabetes Care. 2003 Sep;26(9):2701; author reply 2701-3. doi: 10.2337/diacare.26.9.2701.
No abstract available

Publication types

  • Letter

MeSH terms

  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Diabetes Mellitus, Type 2 / prevention & control*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Metformin / therapeutic use*
  • Reproducibility of Results

Substances

  • Hypoglycemic Agents
  • Metformin